Neuromodulation News and Research

RSS

New transcranial magnetic stimulation array can help stimulate deeper tissue within the brain

As a noninvasive neuromodulation method, transcranial magnetic stimulation (TMS) shows great potential to treat a range of mental and psychiatric diseases, including major depression.

29 Nov 2022

Neurotechnology shows potential for future medical interventions in humans

Neurotechnology -; the combination of neuroscience and technology -; has the potential to both "decode" and shape brain activity, with important implications for future interventions in humans.

9 Nov 2022

Study shows how brain's sensitivity to regret may be altered in mood disorders

Researchers from the Icahn School of Medicine at Mount Sinai have learned that the way the brain processes the complex emotion of regret may be linked to an individual's ability to cope with stress, and altered in psychiatric disorders like depression.

19 Oct 2022

Distinct brain networks may be potential targets for neuromodulation therapies to treat depression

A new study that links the location of brain injury to levels of depression in patients following the injury has identified two distinct brain networks; one associated with increased depression symptoms and one associated with decreased depression symptoms.

13 Oct 2022

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

6 Sep 2022

Study moves one step closer to providing a more efficient treatment for age-related memory loss

According to the Alzheimer's Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer's in 2022. That figure is predicted to nearly double by 2050.

29 Aug 2022

Brain stimulation improves memory function in older adults

Researchers evaluate the effectiveness of repetitive neuromodulation in improving the working memory and long-term memory of older adults.

25 Aug 2022

Functional architecture of the brain's reward system predicts appetite changes in depression

Major depressive disorders are characterized by a significant health burden, including changes in appetite and body weight.

24 Aug 2022

Breakthrough technology brings flexible implanted electronics one step closer toward clinical applications

Flexible implanted electronics are a step closer toward clinical applications thanks to a recent breakthrough technology developed by a research team from Griffith University and UNSW Sydney.

10 Aug 2022

Identifying the right non-pharmacologic treatments for patients with memory impairment

What's the best way to improve your memory as you age? Turns out, it depends, a new study suggests. But your fourth-grade math teacher may have been onto something with that phrase to help you remember how to work out a complicated problem: Please Excuse My Dear Aunt Sally.

22 Jul 2022

New collaborative work wins Neuromod Prize to accelerate the development of neuromodulation therapies

The pioneering collaborative work being performed by Kessler Foundation scientists in the Tim and Caroline Reynolds Center for Spinal Stimulation team has been recognized with the Neuromod Prize, a new initiative from the National Institutes of Health (NIH) Common Fund's Stimulating Peripheral Activity to Relieve Conditions (SPARC) program.

22 Jul 2022

New non-invasive treatment for patients suffering from treatment-resistant depression and dementia

A joint research team from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and City University of Hong Kong (CityU) has discovered that the electrical stimulation of the eye surface can alleviate depression-like symptoms and improve cognitive function in animal models.

8 Jul 2022

Researchers localize specific brain circuit mediating addiction remission

In the United States, substance use disorders are a leading cause of death among young people. Treatments such as deep brain stimulation hold promise for helping people overcome addiction, but many questions remain about what brain areas should be targeted.

13 Jun 2022

The effectiveness of non-pharmacological treatments for post-viral syndromes and long COVID

A recent systematic review investigated the effectiveness of non-pharmacologic interventions for post-viral syndromes, including the post-COVID-19 syndrome.

9 Jun 2022

Neuroscientists study the formation of fear memories in the brain's emotional hub

Experiencing a frightening event is likely something you'll never forget. But why does it stay with you when other kinds of occurrences become increasingly difficult to recall with the passage of time?

1 Jun 2022

Novel network analysis technology can pinpoint seizure originating brain regions in minutes

Fresh techniques to aid seizure diagnosis and surgical planning stand to benefit millions of epilepsy patients, but the path to progress has been slow and challenging.

12 May 2022

High-frequency spinal cord stimulation proves to be more effective at improving perceived pain reduction

Spinal cord stimulation (SCS) for chronic pain involves delivering low levels of electricity directly into the spinal cord using an implanted device, which modifies or blocks nerve activity to minimize the sensation of pain reaching the brain.

28 Apr 2022

Wireless remote care platform may help manage neurological disorders at home

Many neurological disorders like Parkinson's, chronic depression and other psychiatric conditions could be managed at home, thanks to a collaborative project involving researchers at the University of Queensland (UQ).

10 Apr 2022

GE-led team uses ultrasound to prevent or reverse Type-2 diabetes in preclinical models

Are we moving closer to the day when diabetes is no longer monitored and managed with blood sugar tests, insulin injections and drug treatments? A GE Research-led team, which includes The Feinstein Institutes for Medical Research, UCLA Samueli School of Engineering, Yale School of Medicine, and Albany Medical College, has demonstrated the ability to prevent or reverse the onset of diabetes in studies of three different preclinical model systems.

31 Mar 2022

Researchers use optoacoustics for high-precision neuromodulation

Neuromodulation plays an important role in deciphering neural circuits and exploring clinical treatment of neurological diseases.

28 Mar 2022